Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways

摘要

Precision medicine approaches make it possible to tailor medical interventions, including combinations, to individual patients at presentation and potentially throughout the course of their disease as new mutations arise and response to treatment diminishes. However, the concept poses challenges to researchers, patients, regulators and payers.